International Flavors & Fragrances (IFF) Faces Mixed Market Reactions Following Q3 Earnings
New York-based International Flavors & Fragrances Inc. (IFF) is a global leader in high-value ingredients and solutions for food and beverage, home and personal care, and health & wellness markets. With a market cap of $23 billion, the company’s operations span the Americas, Indo-Pacific, and EMEA regions, and command expertise in bioscience, chemistry, flavors, and fragrances.
Stock Performance Lags Behind Market Trends
Over the past year, International Flavors has struggled to keep pace with the broader market. IFF stock has gained 10.9% year-to-date (YTD) and around 22% over the last year. In comparison, the S&P 500 Index ($SPX) has posted gains of 24.7% in 2024 and 31.1% over the previous year.
Despite this, when evaluated against a sector-specific ETF, IFF has outperformed the Materials Select Sector SPDR Fund’s (XLB) returns of 9.4% in 2024 and 15.9% over the past 52 weeks.
Stock Reaction Post-Earnings Report
Despite a positive earnings report, IFF experienced a steep decline of 11.6% in stock prices following its Q3 earnings release on November 5. This sharp drop was particularly striking given the broader market rally observed shortly after the announcement of the Presidential elections results on November 6. IFF’s adjusted EPS rose 16.9% year-over-year to $1.04. However, this improvement primarily stemmed from a comparison against a notably weak Q3 2022 when the company reported earnings of just $0.89 per share, down from $1.36. Additionally, missing analysts’ expectations by 1.9% raised concerns among investors.
Strong Sales Growth Amidst Challenges
On a brighter note, IFF’s net sales increased by 3.7% year-over-year to $2.9 billion, beating Wall Street’s revenue forecasts. On a currency-neutral basis, significant growth was reported in the Health & Biosciences and Scent segments, along with high single-digit growth in the Nourish and Pharma Solutions segments. This upward trend was largely driven by a market recovery leading to substantial volume growth across all divisions.
As for the current fiscal year ending in December, analysts project a 24.6% year-over-year increase in adjusted EPS to $4.16. IFF’s earnings surprise history has been mixed; it has exceeded expectations twice in the last four quarters while falling short on two other occasions.
Analyst Ratings Show Moderate Confidence
Consensus among analysts indicates a “Moderate Buy” rating for IFF stock. Out of 19 analysts covering the stock, 12 recommend “Strong Buy,” one suggests “Moderate Buy,” five recommend “Hold,” and one gives a “Strong Sell” rating.
Analyst Upgrades Reflect Changing Sentiments
This assessment is a more positive outlook than a month ago when only 10 analysts had assigned a “Strong Buy” rating. On November 12, Morgan Stanley (MS) analyst Lisa De Neve upgraded IFF to a “Buy” with a price target of $110, suggesting a potential upside of 22.5% from its current levels.
The mean price target for IFF stands at $103.95, reflecting a 15.8% premium compared to current prices, while the highest target from analysts of $117 suggests a significant potential upside of 30.3%.
On the date of publication, Aditya Sarawgi did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article are solely for informational purposes. For more information, please view the Barchart Disclosure Policy here. More news from Barchart
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
